Hereditary Colorectal Cancer and Polyposis Panel
Use
This test is for individuals with relevant features who have a clinical or suspected diagnosis of hereditary colorectal cancer. It is suitable for individuals with early-onset colorectal tumors diagnosed before age 50 and/or those with at least 20 colon polyps. It can also be used for individuals with multiple, multifocal, or recurrent colorectal tumors, as well as those with a family history of colorectal cancer and/or multiple colon polyps in first-, second-, and third-degree relatives.
Special Instructions
The test utilizes the PGselect Platform and includes CNV analysis. STAT testing is available with a faster turnaround upon request. Results require the patient and any family members to consent to the test after being fully informed about the test's limitations and significance.
Limitations
This test has not been cleared or approved by the US Food and Drug Administration. Although the lab follows CAP and CLIA regulations, results and their interpretations depend on the quality of the clinical information provided. Variants are interpreted with respect to the patient's detailed clinical records, family medical history, and pedigree information.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided